Unknown

Dataset Information

Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies.


ABSTRACT:

Background

Sulfonamide antibacterials are widely used in pregnancy, but evidence about their safety is mixed. The objective of this study was to assess the association between first-trimester sulfonamide exposure and risk of specific congenital malformations.

Methods

Mother-infant pairs were selected from a cohort of 1.2 million live-born deliveries (2001-2008) at 11 US health plans comprising the Medication Exposure in Pregnancy Risk Evaluation Program. Mothers with first-trimester trimethoprim-sulfonamide (TMP-SUL) exposures were randomly matched 1:1 to (i) a primary comparison group (mothers exposed to penicillins and/or cephalosporins) and (ii) a secondary comparison group (mothers with no dispensing of an antibacterial, antiprotozoal, or antimalarial medication during t

SUBMITTER: Hansen C 

PROVIDER: S-EPMC4772767 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature